Name: Rozita Davari-Ashtiani
Qualification: M.D.
Marital status: Married
Work Address: Imam Hossein Hospital, Department of Psychiatry Shahaid Beheshti University of Medical Sciences, Shahid Madani Street Tehran, Iran
Telephone number
Tel: + 98 21 77551023
Fax: + 98 21 77551023
E-mail: rodavari@sbmu.ac.ir
Education
1986-1993: M.D., Urmia University of Medical Sciences, Urmia, Iran
1996-1999: Board of psychiatry, Department of Psychiatry, Tehran University of Medical Sciences, Tehran,Iran
2000-2002: Board of Child &Adolescent Psychiatry, Department of Psychiatry, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Positions held
1994-1996: Director of Nejad Fallah outpatient clinic in Hashtgerd, Iran
2002-Present: Associated Professor of Child & Adolescent Psychiatry Shahid Behashti University of Medical sciences, Tehran, Iran
2005-Present: Member of Iranian Academy of Child & Adolescent Psychiatry (IACAP)
2013-Present: Director of Child and Adolescent Psychiatric Department, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences
2002-2005: Member of National Committee of Life Skills, Mental Health Department, Ministry of Health and Medical Education, Tehran, Iran ,Holding life skills training workshops (training of trainers)
2002-2005: Member of National Committee of Parenting, Mental Health Department, Ministry of Health and Medical Education, Tehran, Iran, Holding parent-training workshops (training of trainers)
2012-2014: Member of Scientific Board of Child & Adolescent Psychiatry of Iran
Course works
2001: Course of Family Therapy, Department of Child & Adolescent Psychiatry, Medical University of Shaheed Beheshti, Tehran, Iran
2001: Course of School Mental Health, Department of Child & Adolescent Psychiatry, Medical University of Shaheed Beheshti, Tehran, Iran
2002: Workshop on research methodology, Institute for Cognitive Science Studies (ICSA) and Yale University. December / 8-10/2002, Tehran, Iran
2004: Certification of Level 4 Group Triple P. Parenting and Family Support Center, University of Queensland, Australia
Publications
Papers
1-Noorbala A.A., Akhondzadeh S., Davari-Ashtinai R. And Amini-Nooshabadi H. (1999). Piracetam in the treatment of schizophrenia: implications for the glutamate, a hypothesis of schizophrenia. Journal of Clinical Pharmacy and Therapeutics, 24, 369-374.
2- Akhondzadeh S., Mohammadi M.A., Amini-Nooshabadi H. And Davari-Ashtiani R. (1999). Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study. Journal of Clinical Pharmacy and Therapeutics, 24, 49-52.
3- Akhondzadeh S., Tavakolian R., Davari-Ashtiani R., Arabgol F., And Amini H. (2003). Selegiline in the treatment of attention defecit hyperactivity disorder in children :a double-blind and randomized trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 841- 845.
4-Amini H., Alaghband-Rad J., Omid A., Sharifi V., Momeni F., Aminipour Z., And Davari-Ashtiani R. (2004). Twelve-Month Diagnostic Stability of First-Episode Psychoses. e-COMMUNITY: International Journal of Mental Health & Addiction, Proceeding of the Mental Health Care in the Gulf (Kuwait), 2004.
5- Amini H., Alaghband-Rad J., Omid A., Sharifi V., Davari-Ashtiani R., Momeni F., And Aminipour Z. (2005). Diagnostic Stability in Patients with First Episode Psychosis. Australasian Psychiatry. 13, 388-392.
6- Alaghband-Rad J, Boroumand M, Amini H, Sharifi V, Omid A, Davari-Ashtiani R, Seddigh A, Momeni F, Aminipour Z. (2006) Non-affective Acute remitting Psychosis: a preliminary report from Iran. Acta Psychiatr Scand, 113: 96-101.
7- Hakimshooshtary, M., Alaghband Rad, J., Sharifi, V., Arabgol, F., Shabani, A., Shahrivar, Z., Shirazi, E., Davari-Ashtiani, R., Tehrani-Doost, M., Amini, H. (2007). Profile of Major Depressive Disorder Symptoms Among Patients in Tehran. Iranian J Psychiatry, 2, 35-41.
8-Sharifi, V.,Assadi, S.M., Mohammadi, M.R., Amini, H., Kaviani, H., Semnani, Y., Shabani, A., Shahrivar, Z., Davari-Ashtiani, R., Hakimshoushtari, M., Sedigh, A., Jalali, M. (2007). Structured Clinical Interview for DSM-IV (SCID): Persian Translation and Cultural Adaptation. Iranian J Psychiatry, 2(1), 46-48.
9-Sharifi, V., Assadi, S. M., Mohammadi, M. R., Amini, H., Kaviani, H., Semnani, Y.,Davari-Ashtiani R, et al. (2009). A Persian translation of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: psychometric properties. Comprehensive Psychiatry, 50(1), 86-91.
10- Davari-Ashtiani, R., Eslami Shahrbabaki, M., Razjouyan, K., Amini, H., Mazhabdar, H. (2010). Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial. Child Psychiatry Hum Dev.(in Press)
11- Sharifi, V.,Assadi, S.M., Mohammadi, M.R., Amini, H., Kaviani, H., Semnani, Y., Shabani, A., Shahrivar, Z., Davari-Ashtiani, R., Hakimshoushtari, M., Sedigh, A., Jalali, M. (2007). Structured Clinical Interview for DSM-IV (SCID): Persian Translation and Cultural Adaptation. Iranian J Psychiatry, 2(1), 46-48
12-Assare,M , Davari-Ashtiani, R , Jazayeri Sh et al (2012)in press. Efficacy of Polyunsaturated Fatty Acids (PUFA) as an adjuvant to Methylphenidate in the the Treatment of children with Attention Deficit Hyperactivity Disorder: a randomized double-blinded placebo-controlled clinical trial.
13- Amini, H, Majdzade ,R, Eftekharsaaabani, A, Davari-Ashtiani, R,How Mental Illness is Perceived by Iranian Medical Students: A Preliminary Study “.(2012) ,Clinical Practice & Epidemiologyin Mental Health, in press
14- Eslami- Amirabadi MR, Esfahani SR , Davari-Ashtiani R, Khademi M, .(2014).. Monoamine Oxidase A Gene Polymorphisms and Bipolar Disorder in Iranian Population, Iranian Red Crescent Medical Journal 17 (2)
15- Eslami Amirabadi MR , Davari-Ashtiani R, Khademi M, RajeziEsfahani S, …(2014) No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population, Iranian Red Crescent Medical Journal 17 (7)
16- Davari-Ashtiani R, Aliabadi B, Khademi M, Arabgol F,( in press), Comparison of creativity between children with and without attention deficit hyperactivity disorder, Iranian journal of Psychiatry in press.
Papers in Persian
17- Shabani A, Sharifi V, Alaghband-rad J, Shahrivar Z, Amini H, Kaviani H, Hakimshooshtari M, Shirazi E, Davari-Ashtiani R, Arabgol F,(2006), Is the comorbidity of Obsessive-Compulsive disorder with Bipolar I disorder less than major depressive disorder?…Iranian Journal of Psychiatry and Clinical Psychology 12 (2), 117-123
18- F Arabgol, J Alaghbandrad, V Sharifi, Sm Hakim, A Shaabani, Davari-Ashtiani R (2005) Reliability of a Persian translation of the Composite International Diagnostic Interview (CIDI), section for substance use disorders: in a multi-center study in Iran, Advances In Cognitive Science 7 (2), 38-45
19- Eslami Shahrbabaki MR, Sabzevari L, Haghdoost A, Davari Ashtiani R (2012). A randomized double blind crossover study on the effectiveness of buspirone and methylphenidate in treatment of attention deficit/hyperactivity disorder in children and adolescents, Iranian Journal of Psychiatry and Clinical Psychology 18 (4), 284-292
20- Davari-Ashtiani R, Jazayeri F, Arabgol F, Razjouyan K, Khademi M (2014). Psychometric Properties of Persian Version of Conners’ Adult Attention Deficit/Hyperactivity Disorder Rating Scale (Screening Form-Self Reporting), Journal of psychiatry and clinical psychology 20 (3), 243-25
21- Davari-Ashtiani R, Parvaresh N, Akhondzadeh SH (2011), Gabapentin as a combination treatment with lithium in adolescents with bipolar disorder: a dou-ble-blind, randomized, placebo-controlled clinical trial International Clinical Psychopharmacology 26, e40
22- Razjoyan K, Davari Ashtiani R, Yavari P, (2007) Soft Neurological Signs in Hyperactive/Inattentive Children, .Iranian Journal of Epidemiology 3 (3), 67-71
23- Asarian F, Davari-Ashtiani R, Arabgol F, Veisanifar R(2005) Comparison of Comorbidity Pattern of Obsessive-compulsive Disorder in Children and Adults with Bipolar Disorder.. Advance in Cognitive Sciences, , Vol7(4), N=28, 43-50.
24- Tashakori A, Arabgol F, Panaghi L., Davari-Ashtiani R.(2007) , The effect of reboxetine in the treatment of depression in children and adolescents. Tehran University Medical Journal, 65(8):40-48
25- Faker H, Davari Ashtiani R, Arabgol F, Rajezi S, Heidarian T, Assarian F (2009), Comparison the Efficacy of Ritalin and Stimdate in Treatment of Attention Deficit Hyperactivity Disorder.. Iranian Journal of Neurology, Volume:7, Number 24:297-303.
Books
Mental Health and Life Skill for women (for psychiatrists and psychologists). Arabgol F, Davari-Ashtiani R, Khazayeli A, Shirazi EL et al. Arvij, Tehran, 2005
Mental Health and Life Skill for women (for mental heath practitioners). Shirazi EL, Khazayeli A, Davari-Ashtiani R, Arabgol F, et al. Arvij, Tehran, 2005
Attention Deficit Hyperactivity Disorder (review of symptoms and current treatments), Davari-Ashtiani R, Ghatre Publication, 2008
Parent training, Shahrivar Z, Arabgol F, Davari-Ashtiani R, Hakim Shooshtari M, Mental Health Office of Ministry of Health and Medical education, 2015
Textbook of clinical psychiatry & behavioral sciences. Psychiatric professors of Iran universities of medical science. 2009.
Providing videos for life skills training in primary schools , Bina M, Davari-Ashtiani R, Aminesmaeeli M, Mahdavi N, 2003